Jazz Pharmaceuticals
$233.01Change from previous close: +0.64%Absolute change: +$1.49
Valuation
Data as of October 2, 2026
Valuation multiples
- Market cap
- $15.13B
- Enterprise value
- $17.34B
- P/E (trailing 12 months)
- 15.9
- Forward P/E
- 9.00
- PEG
- 0.96
- Price/book
- 3.14
- Price/sales
- 3.29
- EV/EBITDA
- 9.00
- EV/revenue
- 3.77
Profitability and growth
- Gross margin
- 91.4%
- Operating margin
- 26.9%
- Net margin
- 20.4%
- ROE
- 22.1%
- ROA
- 6.9%
- Revenue growth (year over year)
- 15.5%
Financial health
- Total cash
- $2.2B
- Total debt
- $4.41B
- Debt/equity
- 0.92
- Current ratio
- 1.78
- Quick ratio
- 1.38
Dividends
- Payout ratio
- 0.0%
Analysts and estimates
- Average price target
- $294.27
- Median price target
- $300.00
- High price target
- $337.00
- Low price target
- $225.00
- Analysts with a price target
- 22
- Consensus
- Strong buy
- Forward EPS
- $25.90
- EPS estimate, current year
- $24.38
Shares and trading
- Beta
- 0.36
- Average volume
- 862.11K
- Shares outstanding
- 64.91M
- Float
- 62.98M
- Institutional ownership
- 102.4%
- Insider ownership
- 2.9%
- Short interest (% of float)
- 7.4%
- Short ratio (days)
- 4.78